IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q2 2019 Holdings

Filed 2019-08-14 | 9 holdings | $19.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$19.3M1,915,27499.3%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$38.1K1,719,5760.2%
Avrobio IncCOM05455M100$31.4K1,930,7040.2%
Sutro Biopharma IncCOM869367102$20.8K1,824,5420.1%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$20.7K918,3370.1%
Transenterix IncCOM NEW89366M201$9.0K6,631,8320.0%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$4.7K311,4900.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.8K628,2360.0%
Catabasis Pharmaceuticals in(CATBEUR)COM NEW14875P206$2.3K285,7650.0%